Market Place
Sourcing Support
Eisai ends lorcaserin development in Dravet syndrome
18 Nov 2024 //
FIERCE PHARMA
Taiwan pulls weight-loss drug from market over cancer concerns
16 Jul 2020 //
TWAIWANNNEWS
Eisai will pull Belviq off U.S. shelves on cancer concerns
14 Feb 2020 //
FIERCE PHARMA
Belviq, Belviq XR by Eisai - FDA Requests Withdrawal of Weight-Loss Drug
14 Feb 2020 //
FDA
FDA Warns of Potential Cancer Risk With Weight Loss Drug
14 Jan 2020 //
RAPS
Zydus Receives USFDA Tentative Approval For Lorcaserin Hydrochloride Tablet
03 Dec 2019 //
PHARMABIZ
United Therapeutics pays $800M-plus to grab Arena’s PhIII PAH drug
16 Nov 2018 //
ENDPTS
Eisai signs pact with Eurofarma for anti-obesity agent
16 Oct 2018 //
BIOSPECTRUM
Weight Loss Drug Does Not Increase Cardiovascular Events
27 Aug 2018 //
R&DMAG
UC San Diego researchers uncover root of leptin resistance
24 Aug 2018 //
ENDPTS
Eisai obesity drug Belviq may have an edge with new heart safety data
19 Jul 2018 //
FIERCE PHARMA
With debt looming, browbeaten diet pill maker Orexigen goes bankrupt
13 Mar 2018 //
ENDPTS
Eisai`s Lenvima moves toward Nexavar showdown with phase 3 liver cancer win
26 Jan 2017 //
FIERCE PHARMA
SoCal Biotech Arena Officially Bails on Weight Loss Drug to Focus on New Product
05 Jan 2017 //
BIOSPACE
Eisai Acquires All Global Development & Marketing Rights For Lorcaserin HCI
05 Jan 2017 //
PR NEWSWIRE
Drug maker faces a shareholder suit for failing to tell the whole truth
28 Oct 2016 //
STAT
Eisai`s LENVIMA Nominated for Galien Foundation`s Best Pharmaceutical Product
26 Oct 2016 //
PR NEWSWIRE
Eisai introduces once-daily chronic weight management drug, Belviq 20mg tablets
04 Oct 2016 //
PHARMABIZ
Eisai Inc. & Arena Announce FDA Approval Of BELVIQ XR (Lorcaserin Hcl)
19 Jul 2016 //
FDA
Eisai & Arena Pharmaceuticals Announce Regulatory Approval of VENESPRI in Mexico
15 Jul 2016 //
PR NEWSWIRE
Orexigen buys US obesity pill rights from partner Takeda
16 Mar 2016 //
REUTERS
Future obesity drugs must provide improved efficacy & safety,says GBI Research
17 Dec 2015 //
CPHI-ONLINE
Struggling Eisai looks for help in China with new generics deal
04 Dec 2015 //
FIERCE PHARMA
Eisai and Arena Pharmaceuticals Announce Completion of Enrollment in BELVIQ®
01 Dec 2015 //
PR NEWS WIRE
Arena Pharma Soars on FDA Approval
30 Nov 2015 //
24/7 WALLST
Eisai & Arena Announce FDA Acceptance of NDA for Extended Release of Lorcaserin
30 Nov 2015 //
PR NEWS WIRE
Are Takeda`s 900 Contrave reps worth it? Maybe not, analyst says
09 Nov 2015 //
FIERCE PHARMA MARKETING
Arena Issue Additional Patent Covering BELVIQ® by US Patent & Trademark Office
27 Oct 2015 //
PR NEWS WIRE
Investors cheer as Arena forces out CEO and cofounder
06 Oct 2015 //
FIERCE PHARMA
Eisai launches thyroid cancer therapy Lenvima in UK
10 Jun 2015 //
PM LIVE
Brutal honesty in drug marketing? For obesity meds, it`s key to avoiding the `magic pill` trap
09 Jun 2015 //
FIERCE PHARMA MARKETING
UPDATED: Eisai to Shed 200-plus Jobs as it Pares Down U.S. Workforce
10 Apr 2015 //
FIERCE PHARMA
Vivus Goes on a Diet: Sales Reps are Cut, but Will FDA Help Save Money?
02 Apr 2015 //
PHARMALOT
Is Europe Softening on Diet Drugs?
28 Mar 2015 //
MEDPAGE TODAY
Eisai Gets EMA Nod For Lenvima Just Weeks After FDA Approval
28 Mar 2015 //
FIERCE PHARMA
Surprise: Obesity Med Contrave Might Help CV Outcomes. Too Bad Orexigen Blabbed It
05 Mar 2015 //
FIERCE PHARMA
Eisai Says Its New Thyroid Cancer Drug is a Sure Blockbuster
16 Feb 2015 //
FIERCE BIOTECH
Belviq Receives Ministry of Food and Drug Safety Marketing Nod for Weight Management in South Korea
05 Feb 2015 //
PHARMABIZ
Arena Pharmaceuticals BELVIQ (Lorcaserin HCl) Approved in South Korea for Weight Management
03 Feb 2015 //
PRESS RELEASE
B-Lipo Capsules by Bethel Nutritional Consulting, Inc. Recall - Undeclared Drug Ingredient
19 Dec 2014 //
EIN NEWSDESK
